HERON THERAPEUTICS, INC. /DE/ (HRTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of HRTX. The 7-day demo opens the 1M and 3M ranges and puts HRTX on your watchlist.
Start 7-day demoLatest HRTX insider trades
About HERON THERAPEUTICS, INC. /DE/ (HRTX)
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
- SAN DIEGO, CA
- 128
- 1987
- XNAS
HRTX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 22 | 396,132 | |
| Tax withholding / forfeiture | 7 | 24,940 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
HRTX insider transactions (Form 4)
4351 Form 4 filings on record, the earliest from Oct 21, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Ira Duarte - Officer | Option exercise | Common Stock | 3,875 | - footnote F1 | - | |
| Ira Duarte - Officer | Option exercise | Restricted Stock Units | 3,875 | $0.00 | - | |
| ||||||
 Craig A. Collard - Officer | Option exercise | Common Stock | 13,797 | - footnote F1 | - | |
| Craig A. Collard - Officer | Option exercise | Restricted Stock Units | 13,797 | $0.00 | - | |
| ||||||
| Thomas Cusack | Grant or award | Common Stock | 37,879 | - footnote F2 | - | |
| Thomas Cusack | Grant or award | Stock Option (Right to Buy) | 227,272 | $1.10 | $250K | |
| ||||||
| William P. Forbes - Officer | Option exercise | Restricted Stock Units | 11,694 | $0.00 | - | |
| William P. Forbes - Officer | Option exercise | Common Stock | 11,694 | - footnote F1 | - | |
| ||||||
| Ira Duarte - Officer | Option exercise | Common Stock | 11,694 | - footnote F1 | - | |
| Ira Duarte - Officer | Option exercise | Restricted Stock Units | 11,694 | $0.00 | - | |
| ||||||
| Craig A. Collard - Officer | Option exercise | Common Stock | 34,789 | - footnote F1 | - | |
| Craig A. Collard - Officer | Option exercise | Restricted Stock Units | 34,789 | $0.00 | - | |
| ||||||
| William P. Forbes - Officer | Option exercise | Common Stock | 3,874 | - footnote F1 | - | |
| William P. Forbes - Officer | Option exercise | Restricted Stock Units | 3,874 | $0.00 | - | |
| ||||||
| Ira Duarte - Officer | Option exercise | Common Stock | 3,874 | - footnote F1 | - | |
| Ira Duarte - Officer | Option exercise | Restricted Stock Units | 3,874 | $0.00 | - | |
| ||||||
| Craig A. Collard - Officer | Option exercise | Common Stock | 13,797 | - footnote F1 | - | |
| Craig A. Collard - Officer | Option exercise | Restricted Stock Units | 13,797 | $0.00 | - | |
| ||||||
| Rubric Capital Management LP - 10% Owner | Other | Common Stock, par value $0.01 per share ("Common Stock") | 946,100 | - footnote F1 | - | |
| Rubric Capital Management LP - 10% Owner | Other | Series A Convertible Preferred Stock ("Preferred Shares") | 94,610 | $0.00 | - | |
| ||||||
| Rubric Capital Management LP - 10% Owner | Open-market purchase | Common Stock, par value $0.01 per share (Common Stock) | 2,387,225 | $1.50 | $3.58M | |
| Rubric Capital Management LP - 10% Owner | Open-market purchase | Convertible Senior Unsecured Promissory Notes (Notes) | 0 | $33,250,000.00 | - | |
| Rubric Capital Management LP - 10% Owner | Open-market purchase | Series A Convertible Preferred Stock (Preferred Shares) | 94,610 | $15.00 | $1.42M | |
| Adam Morgan - Director | Open-market purchase | Common Stock | 1,766,546 | $1.50 | $2.65M | |
| Adam Morgan - Director | Open-market purchase | Series A Convertible Preferred Stock | 70,012 | $15.00 | $1.05M | |
| Craig A. Collard - Officer | Option exercise | Common Stock | 34,789 | - | - | |
| Craig A. Collard - Officer | Option exercise | Restricted Stock Units | 34,789 | $0.00 | - | |
| William P. Forbes - Officer | Option exercise | Common Stock | 11,695 | - | - | |
| William P. Forbes - Officer | Option exercise | Restricted Stock Units | 11,695 | $0.00 | - | |
| Ira Duarte - Officer | Option exercise | Common Stock | 3,874 | - | - | |
| Ira Duarte - Officer | Option exercise | Restricted Stock Units | 3,874 | $0.00 | - | |
| Craig A. Collard - Officer | Option exercise | Common Stock | 13,797 | - | - | |
| Craig A. Collard - Officer | Option exercise | Restricted Stock Units | 13,797 | $0.00 | - | |
| William P. Forbes - Officer | Option exercise | Common Stock | 3,874 | - | - | |
| William P. Forbes - Officer | Option exercise | Restricted Stock Units | 3,874 | $0.00 | - | |
| Michael Kaseta | Grant or award | Common Stock | 37,879 | - | - | |
| Michael Kaseta | Grant or award | Stock Option (Right to Buy) | 227,272 | $1.78 | $405K | |
| Ira Duarte - Officer | Option exercise | Restricted Stock Units | 3,874 | $0.00 | - | |
| Ira Duarte - Officer | Option exercise | Common Stock | 3,874 | - | - | |
| Craig A. Collard - Officer | Option exercise | Common Stock | 13,797 | - | - | |
| Craig A. Collard - Officer | Option exercise | Restricted Stock Units | 13,797 | $0.00 | - | |
| William P. Forbes - Officer | Option exercise | Common Stock | 3,874 | - | - | |
| William P. Forbes - Officer | Option exercise | Restricted Stock Units | 3,874 | $0.00 | - | |
Item 1.01, 9.01
Item 1.01, 3.03, 9.01
Item 2.02, 9.01
Item 3.01, 9.01
HRTX insider trading FAQ
What is the latest insider trade for HRTX?
HERON THERAPEUTICS, INC. /DE/ (HRTX) had 8 insider filings in the last 90 days, with the most recent on 2026-08-10. The full record for HRTX runs to 51 Form 4 filings, the earliest from 2024-10-21. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying HRTX stock?
No insider purchases of HRTX were filed in the last 90 days. 5 purchases are on record for this company.
How many insiders are selling HRTX stock?
No insider sales of HRTX were filed in the last 90 days.
Where can I see HRTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects HRTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mark Earl Hensley view on EDGAR
- - Mark Earl Hensley view on EDGAR
- - William P. Forbes view on EDGAR
- - Ira Duarte view on EDGAR
- - Craig A. Collard view on EDGAR
- - Craig A. Collard view on EDGAR
- - William P. Forbes view on EDGAR
- - Ira Duarte view on EDGAR
- - Ira Duarte view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where HRTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow HRTX with a 7-day demo
- HRTX on your watchlist
- Every HRTX Form 4 filing on record
- Up to 3 months of HRTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
